Impaired microRNA processing enhances cellular transformation and tumorigenesis
- PMID: 17401365
- DOI: 10.1038/ng2003
Impaired microRNA processing enhances cellular transformation and tumorigenesis
Abstract
MicroRNAs (miRNAs) are a new class of small noncoding RNAs that post-transcriptionally regulate the expression of target mRNA transcripts. Many of these target mRNA transcripts are involved in proliferation, differentiation and apoptosis, processes commonly altered during tumorigenesis. Recent work has shown a global decrease of mature miRNA expression in human cancers. However, it is unclear whether this global repression of miRNAs reflects the undifferentiated state of tumors or causally contributes to the transformed phenotype. Here we show that global repression of miRNA maturation promotes cellular transformation and tumorigenesis. Cancer cells expressing short hairpin RNAs (shRNAs) targeting three different components of the miRNA processing machinery showed a substantial decrease in steady-state miRNA levels and a more pronounced transformed phenotype. In animals, miRNA processing-impaired cells formed tumors with accelerated kinetics. These tumors were more invasive than control tumors, suggesting that global miRNA loss enhances tumorigenesis. Furthermore, conditional deletion of Dicer1 enhanced tumor development in a K-Ras-induced mouse model of lung cancer. Overall, these studies indicate that abrogation of global miRNA processing promotes tumorigenesis.
Comment in
-
MicroRNAs as tumor suppressors.Nat Genet. 2007 May;39(5):582-3. doi: 10.1038/ng0507-582. Nat Genet. 2007. PMID: 17460676 No abstract available.
Similar articles
-
Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.J Pathol. 2013 Feb;229(3):400-9. doi: 10.1002/path.4135. J Pathol. 2013. PMID: 23132766
-
Potential microRNA therapies targeting Ras, NFkappaB and p53 signaling.Curr Opin Mol Ther. 2010 Apr;12(2):147-57. Curr Opin Mol Ther. 2010. PMID: 20373258 Review.
-
A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.Oncogene. 2006 Oct 9;25(46):6188-96. doi: 10.1038/sj.onc.1209913. Oncogene. 2006. PMID: 17028598 Review.
-
Extensive post-transcriptional regulation of microRNAs and its implications for cancer.Genes Dev. 2006 Aug 15;20(16):2202-7. doi: 10.1101/gad.1444406. Epub 2006 Aug 1. Genes Dev. 2006. PMID: 16882971 Free PMC article.
-
MicroRNAs: small but potent oncogenes or tumor suppressors.Curr Opin Investig Drugs. 2006 Jun;7(6):560-4. Curr Opin Investig Drugs. 2006. PMID: 16784027 Review.
Cited by
-
Tumor Microenvironment Modulation by Cancer-Derived Extracellular Vesicles.Cells. 2024 Apr 15;13(8):682. doi: 10.3390/cells13080682. Cells. 2024. PMID: 38667297 Free PMC article. Review.
-
Unraveling the Significance of DGCR8 and miRNAs in Thyroid Carcinoma.Cells. 2024 Mar 22;13(7):561. doi: 10.3390/cells13070561. Cells. 2024. PMID: 38607000 Free PMC article. Review.
-
The evolution of preclinical models for myelodysplastic neoplasms.Leukemia. 2024 Apr;38(4):683-691. doi: 10.1038/s41375-024-02181-2. Epub 2024 Feb 23. Leukemia. 2024. PMID: 38396286 Free PMC article. Review.
-
The miR-9-5p/KLF5/IL-1β Axis Regulates Airway Smooth Muscle Cell Proliferation and Apoptosis to Aggravate Airway Remodeling and Inflammation in Asthma.Biochem Genet. 2024 Jan 24. doi: 10.1007/s10528-023-10640-1. Online ahead of print. Biochem Genet. 2024. PMID: 38267617
-
miRNA-Based Technologies in Cancer Therapy.J Pers Med. 2023 Nov 9;13(11):1586. doi: 10.3390/jpm13111586. J Pers Med. 2023. PMID: 38003902 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
